The Effect of Photon Energy on the Intensity-modulated Radiation Therapy Plan for Prostate Cancer: a Planning Study

被引:2
|
作者
Chung, Jin-Beom [1 ]
Kim, Tae-Sung [1 ]
Kim, In-Ah [1 ]
Lee, Jeong-Woo [2 ,3 ]
Cho, Woong [4 ,5 ]
Suh, Tae-Suk [4 ,5 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam 463707, South Korea
[2] Konkuk Univ Hosp, Dept Radiat Oncol, Seoul 143729, South Korea
[3] Korea Univ, Res Inst Hlth Sci, Seoul 136703, South Korea
[4] Catholic Univ Korea, Dept Biomed Engn, Seoul 137701, South Korea
[5] Catholic Univ Korea, Res Inst Biomed Engn, Seoul 137701, South Korea
关键词
HART; Prostate cancer; Photon energy; Treatment planning; DOSE-ESCALATION; TARGET VOLUMES; IMRT TREATMENT; BEAM ENERGY; SHOOT IMRT; RADIOTHERAPY; RISK; IMPLEMENTATION; OPTIMIZATION; MALIGNANCIES;
D O I
10.3938/jkps.59.183
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
In this study, the effect of the beam energy on the intensity modulated radiation therapy (IMRT) plan for prostate cancer was studied for competing IMRT plans optimized for delivery with either 6- or 15-MV photons. This retrospective planning study included 10 patients treated for localized prostate cancer at the Seoul National University Bundang Hospital. A dose of 66 Gy was prescribed in 33 daily fractions of 2 Gy. For inverse IMRT treatment planning, we used a 7-coplanar non-opposed beam arrangement at 0, 50, 100, 150, 210, 260, and 310 degree angles. To ensure that differences among the plans were due only to energy selection, the beam arrangement, number of beam, and close constraints were kept constant for all plans. The dose volume histograms (DVHs) for the 6- and 15-MV plans were compared for the planning target volume (PTV) and for organs at risk (OAR), such as the rectum, bladder and both femoral heads. The conformal index was defined as the ratio of the 95% isodose volume divided by the PTV volume enclosed by the 95% isodose line, because we selected the 95% isodose line as our reference. Doses received by the 95% and 5% volume of the PTV were less than or equal to 1% for 6-MV compared to the 15-MV IMRT plan for 10 patients. Percentage of doses received by the 10% volume of the bladder and rectum were less than or equal to 1%. Percentage of doses received by the 30 and 50% volume of bladder and rectum were 1 similar to 2% higher for 6-MV photons. Also, percentage of dose received by the 10% and 50% volume of the right and the left femur heads were 4 similar to 5% higher for 6-MV photons. The mean homogeneity index for the 6-MV and 15-MV photon plans was 1.06. The mean conformity index of 95% was 1.04 +/- 0.01 and 1.12 +/- 0.02 for 6-MV and 15-MV, respectively, but this difference was not statistically significant. The mean monitor unit was 812 +/- 40 and 716 +/- 33 for the 6-MV and the 15-MV photon plans, respectively. The 6-MV photon plan delivers 13.4% more MU than the 15-MV plan. The-15 MV dose distributions and DVHs of the PTV generated by the clinical treatment planning calculations were as good as, or slightly better than, those generated for 6-MV photons. The organs at risk, such as the rectum, bladder, and femoral head were also similar, with the DVH curve for the 6-MV plan being slightly higher near the low-close region, but lower near the high-dose region. Therefore, we recommend the use of 15-MV photons for IMRT of prostate cancer to achieve better in target coverage, in addition, the integrated dose can be reduce by using IMRT with 15 MV photons.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [31] Explicit and Convex Optimization of Plan Quality Metrics in Intensity-Modulated Radiation Therapy Treatment Planning
    Engberg, L.
    Eriksson, K.
    Forsgren, A.
    Hardemark, B.
    MEDICAL PHYSICS, 2016, 43 (06) : 3802 - 3802
  • [32] Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer
    Hatanaka, Shogo
    Tamaki, Seiichi
    Endo, Haruna
    Mizuno, Norifumi
    Nakamura, Naoki
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (04) : 774 - 779
  • [33] Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly
    Hollenbeck, Brent K.
    Kaufman, Samuel R.
    Yan, Phyllis
    Herrel, Lindsey A.
    Borza, Tudor
    Schroeck, Florian R.
    Jacobs, Bruce L.
    Skolarus, Ted A.
    Shahinian, Vahakn B.
    EUROPEAN UROLOGY, 2018, 73 (04) : 491 - 498
  • [34] Efficacy and toxicity of intensity-modulated radiation therapy for prostate cancer in Chinese patients
    Poon, Darren M. C.
    Chan, Stephen L.
    Leung, Chau M.
    Lee, Kun M.
    Kam, Michael K. M.
    Yu, Brian K. H.
    Chan, Anthony T. C.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (05) : 407 - 415
  • [35] Planning and verification of intensity-modulated arc therapy (IMAT): A prostate case study
    Bedford, J.
    Warrington, A.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S24 - S24
  • [36] Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study
    Ryo Ashida
    Kiyonao Nakamura
    Rihito Aizawa
    Hiraku Iramina
    Kenji Takayama
    Mitsuhiro Nakamura
    Takashi Mizowaki
    Japanese Journal of Radiology, 2022, 40 : 210 - 218
  • [37] Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study
    Ashida, Ryo
    Nakamura, Kiyonao
    Aizawa, Rihito
    Iramina, Hiraku
    Takayama, Kenji
    Nakamura, Mitsuhiro
    Mizowaki, Takashi
    JAPANESE JOURNAL OF RADIOLOGY, 2022, 40 (02) : 210 - 218
  • [38] Comparison of Intensity-Modulated Radiation Therapy, Intensity-Modulated Arc Therapy and Arc-Modulated Radiation Therapy
    Tang, G.
    Earl, M.
    Luan, S.
    Wang, C.
    Naqvi, S.
    Yu, C.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [39] Robust plan optimization using edgeenhanced intensity for intrafraction organ deformation in prostate intensity-modulated radiation therapy
    Sumida, Iori
    Yamaguchi, Hajime
    Das, Indra J.
    Anetai, Yusuke
    Kizaki, Hisao
    Aboshi, Keiko
    Tsujii, Mari
    Yamada, Yuji
    Tamari, Keisuke
    Seo, Yuji
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Ogawa, Kazuhiko
    PLOS ONE, 2017, 12 (03):
  • [40] Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity
    Yu, James B.
    Cramer, Laura D.
    Herrin, Jeph
    Soulos, Pamela R.
    Potosky, Arnold L.
    Gross, Cary P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (12) : 1195 - +